Recently, it is announced, by Shanghai Institute of Optical Precision Machinery of Chinese academy of sciences
With the acceleration of an aging society, the elderly health care has increasingly been becoming a social hot spot.
As one of core and chip suppliers with leading 2 G, 3 G and 4 G wireless communication terminals in China
Recently, on the conference of the twelfth session of TFC global mobile game industry in 2016,
the superintendent founding iHuman Institute of Shanghai Tech University is included in “highly cited scientists in the world in 2015”
On March 22, 2016 Boao Forum for Asia, taking “Asia's future: new vitality and new vision” for the theme of the annual meeting
National protein science research facility (Shanghai) located in Haike Road, Zhangjiang Hi-Tech Park of Pudong (hereinafter referred to as Shanghai facility)
One has to mention Zhangjiang when talking about medical equipment in Shanghai. Zhangjiang has developed the most comprehensive innovation network in bio-medical industry in China.
February 21, 2016, night, the 3-day 16th Annual Conference of YABULI China Enterprise Forum 2016 concluded successfully. Influenced by the trend of “internet +”, the forum invited big shot from internet industry such as Ma Yun, Liu Qiangdong and Yang Yuanqing to discuss the theme of “Confidence and Motivation” and it also adopted the latest way of communication-it cooperated with Ximalaya FM to deliver audio live show for the forum.
China (Shanghai) Free Trade Area pilot area and the Shanghai Zhanjiang National Innovation Demonstration Area are all in Pudong. What will the fusion of the two major national strategies bring? Shanghai’s answer is: to increase the intensity of reform breakthrough in terms of administrative reform, especially the reform of the system.
After examined and adopted by New People's Congress and with the connection with the city’s “13th Five-Year Plan”, the Pudong New Area Economic and Social Development 13th Five-Year Plan has been officially released. “Building an open, innovative, high-quality Pudong”, being easy to remember, becomes the main line of the core concept of Pudong’s “13th Five-Year Plan” and future development.
Recently, Boehringer Ingelheim China biopharmaceutical production base, built jointly by the German pharmaceutical giant Boehringer Ingelheim and Shanghai Zhangjiang Bio-Pharmaceutical Base Development Co., Ltd., has been selected to become the first pilot enterprise to carry out the biopharmaceutical contract manufacturing (CMO) in China. The first product of the pilot project is the immune anti-tumor drug independently developed by BeiGene.